Authors:
Greenbaum, AB
Harrington, RA
Hudson, MP
MacAulay, CM
Wilcox, RG
Simoons, ML
Berdan, LG
Guerci, A
Cokkinos, DV
Kitt, MM
Lincoff, AM
Topol, EJ
Califf, RM
Ohman, EM
Citation: Ab. Greenbaum et al., Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes, J AM COL C, 37(2), 2001, pp. 492-498
Authors:
Lincoff, AM
Harrington, RA
Califf, RM
Hochman, JS
Guerci, AD
Ohman, EM
Pepine, CJ
Kopecky, SL
Kleiman, NS
Pacchiana, CM
Berdan, LG
Kitt, MM
Simoons, ML
Topol, EJ
Citation: Am. Lincoff et al., Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition - Insights from the platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial, CIRCULATION, 102(10), 2000, pp. 1093-1100
Authors:
Kleiman, NS
Lincoff, AM
Flaker, GC
Pieper, KS
Wilcox, RG
Berdan, LG
Lorenz, TJ
Cokkinos, DV
Simoons, ML
Boersma, E
Topol, EJ
Califf, RM
Harrington, RA
Citation: Ns. Kleiman et al., Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes, CIRCULATION, 101(7), 2000, pp. 751-757
Authors:
Barsness, GW
Buller, C
Ohman, M
Schechter, E
Pucillo, A
Taylor, MA
Miller, MJ
Reiner, JS
Churchill, D
Chandler, AB
Gonzalez, M
Smith, J
Tommaso, C
Berdan, LG
Wildermann, NM
Hasdai, D
Holmes, DR
Citation: Gw. Barsness et al., Reduced thrombus burden with abciximab delivered locally before percutaneous intervention saphenous vein grafts, AM HEART J, 139(5), 2000, pp. 824-829
Authors:
McClure, MW
Berkowitz, SD
Sparapani, R
Tuttle, R
Kleiman, NS
Berdan, LG
Lincoff, AM
Deckers, J
Diaz, R
Karsch, KR
Gretler, D
Kitt, M
Simoons, M
Topol, EJ
Califf, RM
Harrington, RA
Citation: Mw. Mcclure et al., Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome - The platelet glycoprotein IIb IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial experience, CIRCULATION, 99(22), 1999, pp. 2892-2900
Authors:
Mahaffey, KW
Harrington, RA
Simoons, ML
Granger, CB
Graffagnino, C
Alberts, MJ
Laskowitz, DT
Miller, JM
Sloan, MA
Berdan, LG
MacAulay, CM
Lincoff, AM
Deckers, J
Topol, EJ
Califf, RM
Citation: Kw. Mahaffey et al., Stroke in patients with acute coronary syndromes - Incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial, CIRCULATION, 99(18), 1999, pp. 2371-2377
Authors:
Alexander, JH
Harrington, RA
Tuttle, RH
Berdan, LG
Lincoff, AM
Deckers, JW
Simoons, ML
Guerci, A
Hochman, JS
Wilcox, RG
Kitt, MM
Eisenberg, PR
Califf, RM
Topol, EJ
Karsh, K
Ruzyllo, W
Stepinska, J
Widimsky, P
Boland, JB
Armstrong, PW
Citation: Jh. Alexander et al., Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes, AM J CARD, 83(8), 1999, pp. 1147-1151
Authors:
Harrington, RA
Califf, RM
Holmes, DR
Pieper, KS
Lincoff, AM
Berdan, LG
Thompson, TD
Topol, EJ
Citation: Ra. Harrington et al., Is all unstable angina the same? Insights from the Coronary Angioplasty Versus Excisional Atherectamy Trial (CAVEAT-I), AM HEART J, 137(2), 1999, pp. 227-233